IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bios Capital Management, LP

Q2 2026 Holdings

Filed 2026-08-14 | 9 holdings | $41.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Actuate Therapeutics Inc(ACTU)COM005083100$15.4M10,049,99636.9%
Opus Genetics Inc(IRD)COM67577R102$15.1M3,683,42936.3%
Cognition Therapeutics Inc(CGTX)COM19243B102$6.9M6,000,00016.6%
Rein Therapeutics Inc(RNTX)COM NEW00887A204$3.1M2,982,3757.4%
Lantern Pharma Inc(LTRN)COM51654W101$1.0M249,3972.5%
In8bio Inc(INAB)COM NEW45674E208$114.1K80,9570.3%